BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 10930992)

  • 41. Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials.
    Lie SO; Abrahamsson J; Clausen N; Forestier E; Hasle H; Hovi L; Jonmundsson G; Mellander L; Gustafsson G
    Br J Haematol; 2003 Jul; 122(2):217-25. PubMed ID: 12846889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia.
    Raimondi SC; Pui CH; Hancock ML; Behm FG; Filatov L; Rivera GK
    Leukemia; 1996 Feb; 10(2):213-24. PubMed ID: 8637229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The detection and significance of chromosomal abnormalities in childhood acute lymphoblastic leukaemia.
    Harrison CJ
    Blood Rev; 2001 Mar; 15(1):49-59. PubMed ID: 11333138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23; p13) or its derivative.
    Pui CH; Raimondi SC; Hancock ML; Rivera GK; Ribeiro RC; Mahmoud HH; Sandlund JT; Crist WM; Behm FG
    J Clin Oncol; 1994 Dec; 12(12):2601-6. PubMed ID: 7989935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group.
    Heerema NA; Sather HN; Sensel MG; Kraft P; Nachman JB; Steinherz PG; Lange BJ; Hutchinson RS; Reaman GH; Trigg ME; Arthur DC; Gaynon PS; Uckun FM
    J Clin Oncol; 1998 Apr; 16(4):1270-8. PubMed ID: 9552025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Favorable prognosis associated with hyperdiploidy in children with acute lymphocytic leukemia correlates with extra chromosome 6. A Pediatric Oncology Group study.
    Jackson JF; Boyett J; Pullen J; Brock B; Patterson R; Land V; Borowitz M; Head D; Crist W
    Cancer; 1990 Sep; 66(6):1183-9. PubMed ID: 2205354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Abnormalities of chromosome bands 13q12 to 13q14 in childhood acute lymphoblastic leukemia.
    Heerema NA; Sather HN; Sensel MG; Lee MK; Hutchinson RJ; Nachman JB; Reaman GH; Lange BJ; Steinherz PG; Bostrom BC; Gaynon PS; Uckun FM
    J Clin Oncol; 2000 Nov; 18(22):3837-44. PubMed ID: 11078497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities.
    Moorman AV; Raimondi SC; Pui CH; Baruchel A; Biondi A; Carroll AJ; Forestier E; Gaynon PS; Harbott J; Harms DO; Heerema N; Pieters R; Schrappe M; Silverman LB; Vilmer E; Harrison CJ;
    Leukemia; 2005 Apr; 19(4):557-63. PubMed ID: 15744345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute leukaemia in children with Down syndrome: a population-based Nordic study.
    Zeller B; Gustafsson G; Forestier E; Abrahamsson J; Clausen N; Heldrup J; Hovi L; Jonmundsson G; Lie SO; Glomstein A; Hasle H;
    Br J Haematol; 2005 Mar; 128(6):797-804. PubMed ID: 15755283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytogenetic pattern of childhood leukemia in Taiwan.
    Yang CP; Wu JH; Hung IJ; Jaing TH
    J Formos Med Assoc; 2000 Apr; 99(4):281-9. PubMed ID: 10870310
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial.
    Moorman AV; Ensor HM; Richards SM; Chilton L; Schwab C; Kinsey SE; Vora A; Mitchell CD; Harrison CJ
    Lancet Oncol; 2010 May; 11(5):429-38. PubMed ID: 20409752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
    von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
    J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
    Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
    Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Age- and sex-specific incidence of childhood leukemia by immunophenotype in the Nordic countries.
    Hjalgrim LL; Rostgaard K; Schmiegelow K; Söderhäll S; Kolmannskog S; Vettenranta K; Kristinsson J; Clausen N; Melbye M; Hjalgrim H; Gustafsson G
    J Natl Cancer Inst; 2003 Oct; 95(20):1539-44. PubMed ID: 14559876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group.
    Uckun FM; Sensel MG; Sather HN; Gaynon PS; Arthur DC; Lange BJ; Steinherz PG; Kraft P; Hutchinson R; Nachman JB; Reaman GH; Heerema NA
    J Clin Oncol; 1998 Feb; 16(2):527-35. PubMed ID: 9469337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study.
    Michels N; Boer JM; Enshaei A; Sutton R; Heyman M; Ebert S; Fiocco M; de Groot-Kruseman HA; van der Velden VHJ; Barbany G; Escherich G; Vora A; Trahair T; Dalla-Pozza L; Pieters R; Zur Stadt U; Schmiegelow K; Moorman AV; Zwaan CM; den Boer ML
    Lancet Haematol; 2021 Oct; 8(10):e700-e710. PubMed ID: 34560013
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: a long-term follow-up.
    Secker-Walker LM; Chessells JM; Stewart EL; Swansbury GJ; Richards S; Lawler SD
    Br J Haematol; 1989 Jul; 72(3):336-42. PubMed ID: 2765402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of chromosomal translocations on prognosis in childhood acute lymphoblastic leukemia.
    Rubin CM; Le Beau MM; Mick R; Bitter MA; Nachman J; Rudinsky R; Appel HJ; Morgan E; Suarez CR; Schumacher HR
    J Clin Oncol; 1991 Dec; 9(12):2183-92. PubMed ID: 1960559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The frequency and prognostic impact of dic(9;20)(p13.2;q11.2) in childhood B-cell precursor acute lymphoblastic leukemia: results from the NOPHO ALL-2000 trial.
    Zachariadis V; Gauffin F; Kuchinskaya E; Heyman M; Schoumans J; Blennow E; Gustafsson B; Barbany G; Golovleva I; Ehrencrona H; Cavelier L; Palmqvist L; Lönnerholm G; Nordenskjöld M; Johansson B; Forestier E; Nordgren A; ;
    Leukemia; 2011 Apr; 25(4):622-8. PubMed ID: 21242996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
    He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.